ticker
Login
business news
Politics And Regulation
Markets
The Economy
Editor's Pick
trading and investing
Stocks
ETFs
Fixed Income
Earnings
Currencies
Commodities
Options
Taxes
Personal Finance
How To Trade
How To Invest
sectors
Biotech/pharma
Consumer
Energy
Financial
Global Markets
Media
Precious Metals
Real Estate
Technology
Transportation
special features
Wall Of Worry
Random Thoughts
Sports Business
Minyanville Press
Video
Hoofy & Boo
Radio
MV PREMIUM
subscriptions
Launch Buzz And Banter
Buzz And Banter
Elliott Wave Insider
Tchir's Fixed Income Report
Cooper's Market Report
Techstrat Report
Optionsmith
The Stock Playbook
Ad Free Minyanville
Minyanville Book Store
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Hemispherx Biopharma, Inc.
(NY:
HEB
)
0.2000
USD
-0.0005 (-0.25%)
Official Closing Price
/ Updated:
6:40 PM EDT, May 24, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
589,518
Open
0.2000
Bid (Size)
0.1982 (1000)
Ask (Size)
0.2100 (32500)
Prev. Close
0.2005
Today's Range
0.1980 - 0.2100
52wk Range
0.1900 - 1.100
Shares Outstanding
167,229,903
Dividend Yield
N/A
Featured News
More News
A Triple Play Of Biotech Disappointments Last Week (ONTY, FOLD, HEB, GSK)
December 28, 2012
Investors got a triple-dose of bad biotech news this week.
Read More
from
Investopedia Advisor Commentary
Wednesday's biggest gaining and declining stocks
December 02, 2009
Among the shares that are seeing active trading in Wednesday's session are RF Micro Devices, Santarus, GameStop and Walgreen.
Read More
category
SNTS
,
STZ
,
RFMD
, and 4 more.
from
MarketWatch
Featured News
Read More
Dyax rockets, Hemispherx craters on FDA updates
December 02, 2009
category
Market News
,
Biotechnology
,
HEB
, and 7 more.
from
MarketWatch
Stocks in focus for Wednesday
December 01, 2009
category
F
,
Earnings
,
SNTS
, and 14 more.
from
MarketWatch
Oops: I have to eat crow over these 'stupid' picks
June 19, 2009
category
Biotechnology
,
Financial Services
,
Banks
, and 13 more.
from
MarketWatch
Vaccine makers get boost from flu scare
May 21, 2009
category
RHHBY
,
Biotechnology
,
GNBT
, and 12 more.
from
MarketWatch
Drug stocks higher on Dr. Reddy's report
May 18, 2009
category
Earnings
,
Biotechnology
,
HEB
, and 7 more.
from
MarketWatch
Pigs will get slaughtered on swine-flu stocks
April 30, 2009
category
GNVC
,
CPFSX
,
Biotechnology
, and 16 more.
from
MarketWatch
More News
Read More
Hemispherx Biopharma Announces Financial Results for the Three Months Ended March 31, 2013
May 08, 2013
from
GlobeNewswire News Releases
BioCryst (BCRX) Continues Higher on Latest Bird Flu Death
April 12, 2013
from
StreetInsider.com News Articles
Hemispherx Biopharma Announces Financial Results for the Year Ended December 31, 2012
March 18, 2013
from
GlobeNewswire News Releases
Hemispherx Biopharma Gains Broad Treatment Expansion for Alferon N Injection(R) in Argentina
March 04, 2013
from
GlobeNewswire News Releases
UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Hemispherx Biopharma, Inc. of Class Action Lawsuit and the Deadline of February 22, 2013 to Seek a Lead Plaint
February 20, 2013
from
Business Wire News Releases
Rosen Law Firm Reminds Hemispherx Biopharma Investors of Important February 22, 2013 Deadline -- HEB
February 16, 2013
from
GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders of Hemispherx Biopharma of Upcoming Deadline -- HEB
February 15, 2013
from
GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders of Hemispherx Biopharma of Upcoming Deadline -- HEB
February 08, 2013
from
GlobeNewswire News Releases
ShinesRooms Research on Gilead and Hemispherx: Biotech Companies Seek New Pastures
February 07, 2013
from
ACCESSWIRE
Free Research Reports on BIDU, HEB, IDIX and YUM Issued by the Bedford Report
February 06, 2013
from
Marketwired News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Stay Connected
WHAT'S POPULAR IN THE VILLE
1
Google and NASA Make Quantum Leap With New Computer
Josh Wolonick
2
Random Thoughts: A Signal That Bears Watching
Todd Harrison
3
Mother of All Fed Cha-Cha Days or Last Tango on Wall Street?
Jeffrey Cooper
4
Every Trader and Investor Should Be Watching the Dollar
Tom Pizzuti and Kurt Hulse
5
In Insider Trading: Insiders at Emerald Oil and OPKO Health Make Buys, and Cubic Corporation Sees a Major Sale
Josh Wolonick
See All Articles
»